Market Cap (In TWD)
87.6 Billion
Revenue (In TWD)
38.93 Million
Net Income (In TWD)
-488.45 Million
Avg. Volume
554.89 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 240.5-800.0
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- TW0006919004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Yufang Ling
- Employee Count
- -
- Website
- https://www.caliway.com.tw
- Ipo Date
- 2022-12-26
- Details
- Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan.
More Stocks
-
NVAP.A. Nova S.A.
NVA
-
SUNSunoco LP
SUN
-
APGOApollo Silver Corp.
APGO
-
VFCV.F. Corporation
VFC
-
BERGEPAINTBerger Paints India Limited
BERGEPAINT
-
RF-PE
-
WCN
-
HOVEHove A/S
HOVE